Form 4 for ISRG Intuitive Surgical
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-28 · accession 0001035267-23-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-01 | 2023-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | F - Tax | $229.39 | -1,501 | 3,203 | -32% | -$344.3K |
| D | 2023-03-01 | 2023-03-01 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $228.47 | -1,253 | 1,950 | -39% | -$286.3K |
| DM | 2023-03-01 | 2023-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | +3,259 | 3,701 | +737% | $0 |
| DM | 2023-03-01 | 2023-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | A - Grant | $0.00 | +8,380 | 3,352 | New | $0 |
| DM | 2023-03-01 | 2023-02-28 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -3,259 | 3,007 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 1,003 | $229.39 | 2,698 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 1,253 | $228.47 | 1,950 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-28 | M | A | 2,256 | $0.00 | 3,701 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-28 | M | A | 1,003 | $0.00 | 3,701 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-28 | F | D | 498 | $229.39 | 3,203 | D | — | — | |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-28 | A | A | 5,028 | $0.00 | 5,028 | D | $229.39 · — to 2030-02-27 | 5,028 Common Stock | (F3) 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| 7 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 2,256 | $0.00 | 2,253 | D | $0.00 · — to 2024-02-28 | 2,256 Common Stock | (F4) Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. |
| 8 | Derivative | Restricted Stock Units | 2023-02-28 | A | A | 3,352 | $0.00 | 3,352 | D | $0.00 · — to — | 3,352 Common Stock | (F5) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| 9 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 1,003 | $0.00 | 3,007 | D | $0.00 · — to 2026-02-28 | 1,003 Common Stock | (F4) Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. |